Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-27.11	-62.62	-49.26
Graham Fair Price	106.81	13.48	6.52
PEG	-80.67	0.21	-1.07
Price/Book	-33.21	4.23	-6.34
Price/Cash Flow	-21.04	-72.29	-59.73
Prices/Earnings	7.94	-15.78	-17.14
Price/Sales	0.00	0.00	0.00
Price/FCF	-21.04	-72.29	-59.73
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	-84.57	-0.06	-0.03
ROE	0.09	-0.07	-27.46
ROIC	0.13	-0.08	-36.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.02	-11.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	-0.25	-29.49
EPS QOQ	0.16	-0.76	376.19
FCF QOQ	-0.24	-0.34	-45.94
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	-0.06	0.02	-63.36
Quick Ratio	32.16	25.69	-20.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-4.52	10.97	142.81
Cash	11.75	11.17	-4.95
Capex	< 0.005	-0.04	-803.21
Free Cash Flow	-0.48	-0.64	-33.98
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	32.44	25.88	-20.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.46	1.78	-48.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating